BPG is committed to discovery and dissemination of knowledge
Retrospective Study
©The Author(s) 2026.
World J Diabetes. Feb 15, 2026; 17(2): 112856
Published online Feb 15, 2026. doi: 10.4239/wjd.v17.i2.112856
Table 2 Comparison of clinical characteristics between two groups of patients, n (%)/mean ± SD
Parameters
Diabetics group (n = 105)
Non-diabetics group (n = 411)
t/χ2
P value
Tumor location0.1430.705
Convexity/falx62 (59.05)251 (61.07)
Skull base43 (40.95)160 (38.93)
Tumor max diameter (cm)4.23 ± 0.544.26 ± 0.410.5150.607
Tumor max diameter stratification0.0720.789
Less than 5 cm67 (63.81)268 (65.21)
Greater than or equal to 5 cm38 (36.19)143 (34.79)
World Health Organization grade 0.7940.672
I76 (72.38)303 (73.72)
II21 (20.00)86 (20.92)
III8 (7.62)22 (5.35)
Postoperative follow-up (months)38.72 ± 1.0238.71 ± 1.210.0500.960
Glycated hemoglobin (%)7.01 ± 0.464.45 ± 0.5648.368< 0.001
Duration of diabetes (years)3.56 ± 1.04-


Write to the Help Desk